Jeffrey Anderson Douglas Zipes JEFFREY ANDERSON, University of Utah, Salt Lake City COMMENT: DOUGLAS ZIPES, University of Indiana, Indianapolis REFERENCE: Abstract 1020-89, American College of Cardiol

Jeffrey Anderson

Douglas Zipes
JEFFREY ANDERSON, University of Utah, Salt Lake CityCOMMENT: DOUGLAS ZIPES, University of Indiana, Indianapolis
REFERENCE: Abstract 1020-89, American College of Cardiology New OrleansThe hope of refining treatments for cardiovascular disease by genotyping patients to detect individual sensitivities to particular medical therapies was brought a step closer at the ACC meeting in New Orleans by results from a study using a rapid genothype test.Jeffrey Andersontold Peter Goodwin about the assay they’ve been investigating which indicates required dosing of warfarin.
